EXC
76
6
DUK
80
5
MCO
56
-2
CLX
66
-2
FFIV
55
-3
LNC
50
-2
PCAR
42
-7
TRV
52
2
LMT
55
6
OI
39
-4
NUE
44
-2
AAL
20
-6
FE
60
11
BAX
48
-2
INTC
48
16
AZO
63
-2
TGNA
64
-2
PNW
71
2
AMP
61
-2
SO
66
2
EXC
76
6
DUK
80
5
MCO
56
-2
CLX
66
-2
FFIV
55
-3
LNC
50
-2
PCAR
42
-7
TRV
52
2
LMT
55
6
OI
39
-4
NUE
44
-2
AAL
20
-6
FE
60
11
BAX
48
-2
INTC
48
16
AZO
63
-2
TGNA
64
-2
PNW
71
2
AMP
61
-2
SO
66
2
Financhill
Back

Catalyst Pharmaceuticals 10K Form

Buy
73

CPRX
Catalyst Pharmaceuticals

Last Price:
$21.01
Seasonality Move:
14.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CPRX News And Ratings

See the #1 stock for the next 7 days that we like better than CPRX

CPRX Financial Statistics

Sales & Book Value

Annual Sales: $491.7M
Cash Flow: $70.8M
Price / Cash Flow: 10.9
Annual Sales: $6.02
Price / Book: 3.48

Profitability

EPS (TTM): 1.31000
Net Income (TTM): $163.9M
Gross Margin: $422.9M
Return on Equity: 27.81%
Return on Assets: 23.78%

Catalyst Pharmaceuticals Earnings Forecast

Key Catalyst Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 23 years for CPRX is 86.00%.
  • The Selling, General & Administrative Expenses for CPRX have been equal to 36.15% of Gross Profit Margin.
  • The Research & Development expenses have been 2.57% of Revenue.
  • Per Share Earnings over the last 23 years have been positive in 11 years.

Catalyst Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CPRX
CUSIP: 14888U
Website: catalystpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.17
Quick Ratio: 4.83

Price-to-Earnings

Trailing P/E Ratio: 15.93
Forward P/E Ratio: 9.45

CPRX Technical Analysis vs Fundamental Analysis

Buy
73
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy or a Sell?